ACSL6	chr5	131,949,972	132,012,086	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ACSL6 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ADRB2	chr5	148,825,244	148,828,687	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ADRB2 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
AEBP2	chr12	 19,404,065	 19,522,239	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the AEBP2 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ALAS2	chrX	 55,009,055	 55,030,977	minus	NA	NA	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ALAS2 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ANKRD26	chr10	 26,973,793	 27,100,494	minus	Myeloid neoplasms with germline predisposition and pre-existing platelet disorder, (WHO, PMID: 35732831).	Myeloid neoplasms with germline ANKRD26 mutation, (ICC, PMID: 35767897).	NA	NA	No	Yes	No	Deletion/CN loss	LOF	AML	1A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ANKRD26 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
APC	chr5	112,707,504	112,846,239	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the APC gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
AR	chrX	 67,544,031	 67,730,619	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the AR gene on chrX with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ARHGAP26	chr5	142,770,383	143,229,011	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ARHGAP26 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ARNT	chr1	150,809,704	150,876,768	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ARNT gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ASXL2	chr2	 25,733,752	 25,878,516	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ASXL2 gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ATG2B	chr14	 96,279,194	 96,363,341	minus	NA	NA	NA	NA	No	Yes	No	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ATG2B gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ATR	chr3	142,449,235	142,578,733	minus	NA	NA	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ATR gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
BAALC	chr8	103,140,692	103,230,305	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BAALC gene on chr8 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
BCOR	chrX	 40,049,815	 40,177,329	minus	Defining somatic mutations in acute myeloid leukaemia, myelodysplasia-related. Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	Classification of AML with percentage of blasts required for diagnosis. Defined by mutations in ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, or ZRSR2 (ICC, PMID: 35767897)., (ICC, PMID: 35767897).	NA	NA	Core	Yes	Yes	Deletion/CN loss	LOF	AML	1A	NA	Optical Genome Mapping detected a translocation t(X;17)(p11.4;q21.2) or [rearrangement, loss, insertion, deletion] of BCOR with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
BCORL1	chrX	129,982,634	130,058,071	plus	NA	NA	NA	NA	No	Yes	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BCORL1 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
BIN2	chr12	 51,281,037	 51,324,174	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the BIN2 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
BLM	chr15	 90,717,346	 90,816,166	plus	Subtypes of myeloid neoplasms associated with germline predisposition, Myeloid neoplasms with germline predisposition and potential organ dysfunction, (WHO, PMID: 35732831).	NA	NA	NA	No	No	No	Deletion/CN loss	LOF	AML	1A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BLM gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
BRINP3	chr1	190,097,661	190,477,882	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the BRINP3 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CCDC6	chr10	 59,788,747	 59,906,656	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CCDC6 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CDK5RAP2	chr9	120,388,874	120,580,167	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the CDK5RAP2 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CDX2	chr13	 27,960,917	 27,969,315	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the CDX2 gene on chr13 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CHIC2	chr4	 54,009,788	 54,064,690	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CHIC2 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CNTRL	chr9	121,074,954	121,177,610	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the CNTRL gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CRLF2_chrX	chrX	  1,190,489	  1,212,649	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the CRLF2_chrX gene on chrX with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CRLF2_chrY	chrY	  1,190,489	  1,212,649	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the CRLF2_chrY gene on chrY with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CSMD2	chr1	 33,513,998	 34,165,842	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CSMD2 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CSNK1A1	chr5	149,492,196	149,551,552	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CSNK1A1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
CTNNA1	chr5	138,753,424	138,935,034	plus	NA	NA	NA	NA	No	Yes	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the CTNNA1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
DDX41	chr5	177,511,577	177,516,961	minus	Subtypes of myeloid neoplasms associated with germline predisposition; Myeloid neoplasms with germline predisposition without a pre-existing platelet disorder or organ dysfunction, (WHO, PMID: 35732831).	Hematologic neoplasms with germline predisposition without a constitutional disorder affecting multiple organ systems; Myeloid or lymphoid neoplasms with germline DDX41 mutation, (ICC, PMID: 35767897).	NA	NA	Expanded	Yes	Yes	Deletion/CN loss	LOF	AML	1A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the DDX41 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
DHX15	chr4	 24,527,464	 24,584,561	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the DHX15 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
DHX30	chr3	 47,802,908	 47,850,196	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the DHX30 gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
DIAPH1	chr5	141,515,015	141,619,055	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the DIAPH1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
DNMT1	chr19	 10,133,343	 10,195,135	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the DNMT1 gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
EED	chr11	 86,244,383	 86,278,813	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the EED gene on chr11 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
EGLN1	chr1	231,363,750	231,425,044	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the EGLN1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
EGR1	chr5	138,465,478	138,469,303	plus	NA	NA	NA	NA	No	Yes	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the EGR1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ENAH	chr1	225,486,831	225,653,143	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ENAH gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
EP300	chr22	 41,092,591	 41,180,077	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the EP300 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ERCC2	chr19	 45,349,836	 45,370,618	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ERCC2 gene on chr19 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ETFDH	chr4	158,672,100	158,709,623	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the ETFDH gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
ETNK1	chr12	 22,625,170	 22,690,665	plus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the ETNK1 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
FAT1	chr4	186,587,782	186,723,855	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FAT1 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
FAT4	chr4	125,316,398	125,492,932	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FAT4 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
FEV	chr2	218,981,086	218,985,184	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the FEV gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
FGFR1OP	chr6	166,999,181	167,052,713	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FGFR1OP gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
FHIT	chr3	 59,747,277	 61,251,461	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FHIT gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
FIP1L1	chr4	 53,377,640	 53,460,862	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the FIP1L1 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
FOXN3	chr14	 89,156,171	 89,619,150	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the FOXN3 gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
GATA1	chrX	 48,786,589	 48,794,311	plus	NA	NA	NA	NA	Expanded	Yes	Yes	Rearrangement/translocation	FUS	AML	3A	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the GATA1 gene on chrX with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
GIT2	chr12	109,929,803	109,996,368	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the GIT2 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
GNAS	chr20	 58,891,420	 58,911,192	plus	NA	NA	NA	NA	No	Yes	No	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the GNAS gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
GNB1	chr1	  1,785,285	  1,891,087	minus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the GNB1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
GOLGA4	chr3	 37,243,270	 37,366,879	plus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the GOLGA4 gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
GRIA1	chr5	153,490,523	153,813,869	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the GRIA1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
GSKIP	chr14	 96,363,525	 96,387,288	plus	NA	NA	NA	NA	No	Yes	No	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the GSKIP gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
GUCY1B3	chr4	155,758,972	155,807,642	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the GUCY1B3 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
HBS1L	chr6	134,960,377	135,054,898	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HBS1L gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
HIP1	chr7	 75,533,297	 75,738,941	minus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the HIP1 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
HMGA2	chr12	 65,824,130	 65,966,295	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HMGA2 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
HNRNPK	chr9	 83,968,082	 83,980,782	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HNRNPK gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
HOXA11	chr7	 27,181,156	 27,185,216	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HOXA11 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
HOXD11	chr2	176,107,285	176,109,588	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HOXD11 gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
HOXD13	chr2	176,092,803	176,095,938	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HOXD13 gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
HSPA9	chr5	138,554,881	138,575,629	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the HSPA9 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
IRF1	chr5	132,481,608	132,490,773	minus	NA	NA	NA	NA	No	Yes	No	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the IRF1 gene on chr5 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
JARID2	chr6	 15,245,974	 15,522,042	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the JARID2 gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
KANK1	chr9	    504,694	    746,103	plus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the KANK1 gene on chr9 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
KIF5B	chr10	 32,009,014	 32,056,425	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the KIF5B gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
KMT2C	chr7	152,134,924	152,436,005	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the KMT2C gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
KMT2E	chr7	105,014,178	105,114,085	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the KMT2E gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
L3MBTL1	chr20	 43,507,679	 43,541,895	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the L3MBTL1 gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
LAMB1	chr7	107,923,800	108,003,359	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LAMB1 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
LINC00982	chr1	  3,059,616	  3,067,725	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LINC00982 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
LLGL2	chr17	 75,525,701	 75,575,209	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LLGL2 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
LUC7L2	chr7	139,340,358	139,423,457	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the LUC7L2 gene on chr7 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MAL	chr2	 95,025,654	 95,053,996	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MAL gene on chr2 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MAP2K1	chr15	 66,386,816	 66,492,312	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MAP2K1 gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MDS2	chr1	 23,627,333	 23,640,568	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MDS2 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MGA	chr15	 41,621,223	 41,769,943	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MGA gene on chr15 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MKL1	chr22	 40,410,280	 40,636,719	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MKL1 gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MLLT11	chr1	151,057,757	151,068,497	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MLLT11 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MRTFA	chr22	 40,410,281	 40,636,719	minus	Acute myeloid leukaemia with defining genetic abnormalities; Acute myeloid leukaemia with RBM15::MRTFA fusion, (WHO, PMID: 35732831).	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	1A	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the MRTFA gene on chr22 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MSI2	chr17	 57,255,850	 57,684,689	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MSI2 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYB	chr6	135,181,307	135,219,172	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the MYB gene on chr6 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYBL2	chr20	 43,667,018	 43,716,496	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MYBL2 gene on chr20 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYD88	chr3	 38,138,660	 38,143,022	plus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the MYD88 gene on chr3 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYO18A	chr17	 29,073,509	 29,180,412	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MYO18A gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
MYSM1	chr1	 58,654,744	 58,700,062	minus	NA	NA	NA	NA	Expanded	No	No	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the MYSM1 gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
NFE2	chr12	 54,292,110	 54,295,758	minus	NA	NA	NA	NA	No	Yes	No	Duplication/CN gain	GOF	AML	2	NA	Optical Genome Mapping detected a [Duplication/CN gain] mutation involving the NFE2 gene on chr12 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
NIN	chr14	 50,719,762	 50,831,162	minus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the NIN gene on chr14 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
P2RY8_chrX	chrX	  1,462,580	  1,537,185	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the P2RY8_chrX gene on chrX with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
P2RY8_chrY	chrY	  1,462,580	  1,537,185	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the P2RY8_chrY gene on chrY with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PCM1	chr8	 17,922,987	 18,029,948	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the PCM1 gene on chr8 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PDE4DIP	chr1	148,844,427	149,033,016	plus	NA	NA	NA	NA	No	Yes	Yes	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the PDE4DIP gene on chr1 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PER1	chr17	  8,140,469	  8,156,360	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PER1 gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PPM1D	chr17	 60,600,192	 60,666,280	plus	NA	NA	NA	NA	Expanded	Yes	Yes	Deletion/CN loss	LOF	AML	3A	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PPM1D gene on chr17 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PRKG1	chr10	 50,991,150	 52,298,350	NA	NA	NA	NA	NA	No	No	Yes	Deletion/CN loss	LOF	AML	2	NA	Optical Genome Mapping detected a [Deletion/CN loss] mutation involving the PRKG1 gene on chr10 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
PRKG2	chr4	 81,087,374	 81,215,222	minus	NA	NA	NA	NA	No	Yes	No	Rearrangement/translocation	FUS	AML	2	NA	Optical Genome Mapping detected a [Rearrangement/translocation] mutation involving the PRKG2 gene on chr4 with a variant allele frequency (VAF) of [%].	In the context of AML, this variant has unknown prognosis.
